VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTCBB:APNS) (www.AppliedNeuroSolutions.com), a Company focused on the development of products for the early diagnosis and treatment of Alzheimer’s disease (“AD”), recently announced its financial results for the quarter ended March 31, 2008 and today provides highlights on its development program for Q1. The Company has achieved its Q1 diagnostic program milestone and is on-track to meet its upcoming milestones.
